Click image to enlarge
The
V-PLEX platform offers analytically validated singleplex and multiplex assay kits. Developed under rigorous design control, V-PLEX kits provide accurate and reproducible results with consistency from lot to lot. The V-PLEX Plus Human IL-23 Kit enables the measurement of IL-23 in a single-analyte format. For information on multiplexing IL-23 with other analytes, please see
V-PLEX Plus Th17 Panel 1 Human Kit.V-PLEX Plus kits include controls, wash buffer, and plate seals.
Related Key Terms:
CLMF2, NKSF2, p19/IL-12p40 heterodimer, IL-12 cytokine family, interleukin, immunity, inflammation, Th17, autoimmunity, arthritis, diabetes, Crohn's disease, multiple sclerosis, psoriasis
-
-
Specifications
-
-
Documentation
-
References
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
Analyte(s)
|
|
IL-23
|
|
Species
|
|
Human
|
|
Plate Type
|
|
96-well
|
|
Instrument(s)
|
|
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO QuickPlex SQ 120
,
SECTOR Imager 6000
,
SECTOR Imager 2400
|
|
Capture Antibody
|
|
Mouse Monoclonal
|
|
Detection Antibody
|
|
Mouse Monoclonal
|
|
LLOD (Sensitivity)
|
|
0.274 pg/mL
|
|
Dynamic Range
|
|
0.274 - 3,250 pg/mL
|
|
Sample Type
|
|
Serum, Plasma, Cell Culture Supernatant, Urine
|
|
Recombinant standards
|
|
Expressed in Insect cell line
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
Storage Condition
|
|
Multi-Component
|
|
Gene ID(s)
|
|
51561, 3593
|
|
UniProt ID(s)
|
|
Q9NPF7, P29460
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Inserts
|
|
|
Certificate of analysis
|
|
|
SDS
|
|
|
Scientific Posters
|
|
|
Title
|
Journal
|
Year
|
|
Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity
|
|
|
|
Protection Against Lethal Multidrug-Resistant Bacterial Infections Using Macrophage Cell Therapy
|
|
|
|
Structural basis for the dual recognition of IL-12 and IL-23 by ustekinumab.
|
|
|
|
Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.
|
|
|
|
|
Meso Scale Japan 株式会社